Study of Zatolmilast (BPN14770) in Participants With PPP2R5D Neurodevelopmental Disorder (Jordan's Syndrome [JS])

NCT06717438 · clinicaltrials.gov ↗

PHASE2

Phase

ACTIVE_NOT_RECRUITING

Status

30

Enrollment

INDUSTRY

Sponsor class

Conditions

Jordan's Syndrome
PPP2R5D Neurodevelopmental Disorder

Interventions

DRUG: BPN14770
DRUG: Placebo

Sponsor

Shionogi